Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axsome Thera
(NQ:
AXSM
)
87.99
+0.88 (+1.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axsome Thera
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Expert Ratings for Axsome Therapeutics
May 09, 2023
Via
Benzinga
Axsome Therapeutics Clocks Better Than Expected Q1 Sales, Depression Drug Sees Improved Coverage
May 08, 2023
Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q1 revenue of $94.6 million, consisting of net product sales of $28.6 million, license revenue of $65.7 million, and
Via
Benzinga
Axsome Therapeutics (AXSM) Q1 2023 Earnings Call Transcript
May 08, 2023
AXSM earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Axsome Surges As Its Newest Product Shines. But BioXcel Does The Opposite.
May 08, 2023
Axsome shares are nearing a breakout point. But BioXcel crumbled on its report.
Via
Investor's Business Daily
Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
May 08, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Earnings Outlook For Axsome Therapeutics
May 05, 2023
Via
Benzinga
Axsome Therapeutics Stock: Bear vs. Bull
April 23, 2023
Axsome shares beat the bear market last year.
Via
The Motley Fool
2 Beaten-Down Growth Stocks to Buy in April
April 20, 2023
These companies have lucrative opportunities ahead.
Via
The Motley Fool
Could Axsome Therapeutics Stock Help You Become a Millionaire?
April 16, 2023
In the past five years, the stock has risen by nearly 2,400%.
Via
The Motley Fool
Axsome Therapeutics to Present at the Bank of America Securities 2023 Healthcare Conference
May 03, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics Joins Mental Health America and the State of New York to Raise Awareness of Mental Health During May is Mental Health Month
May 01, 2023
One World Trade Center to be lit up in green in observance of Mental Health Month
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
April 28, 2023
Here are three biotech stocks with promising innovations that could provide catalysts for their respective stocks in 2023
Via
InvestorPlace
NASDAQ: AXSM Shareholder Notice: Investigation over Potential Wrongdoing at Axsome Therapeutics, Inc.
April 27, 2023
San Diego, CA -- (SBWIRE) -- 04/27/2023 -- Certain directors of Axsome Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Is It Too Late to Buy Axsome Therapeutics Stock?
April 15, 2023
With two major catalysts in the rearview mirror, it's easy to think that it's too late.
Via
The Motley Fool
What 10 Analyst Ratings Have To Say About Axsome Therapeutics
April 12, 2023
Via
Benzinga
3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat
April 25, 2023
Discover the latest picks in the biotech industry with our article on 3 biotech stocks to watch after Johnson & Johnson’s earnings beat.
Via
InvestorPlace
If You Invested $5,000 in Axsome Therapeutics 5 Years Ago, Here's How Much You Would Have Now
April 25, 2023
Axsome's new products have blockbuster potential.
Via
The Motley Fool
3 Stocks With Huge Catalysts on the Way
April 22, 2023
Big news could mean big boosts for these stocks.
Via
The Motley Fool
Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of SUNOSI® (solriamfetol) in Participants with Cognitive Impairment with Excessive Daytime Sleepiness in Obstructive Sleep Apnea at the 2023 American Academy of
April 21, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
The Top 3 Biotech Stocks to Watch in 2023
April 20, 2023
Investors would be wise to keep an eye on the biotech boom, and these top biotech stocks to watch as we get deeper into 2023.
Via
InvestorPlace
1 Risky Growth Stock Wall Street Says Is Poised for a 47% Rally
April 20, 2023
Its price should keep rising, but perhaps Wall Street is a bit enthusiastic with its forecasts.
Via
The Motley Fool
The Top Healthcare Stocks to Buy With $100
April 18, 2023
A small investment now may bring big results over time.
Via
The Motley Fool
Better Growth Stock: Axsome vs. CRISPR Therapeutics
April 16, 2023
These companies are both in the early days of their growth stories.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 14, 2023
Via
Benzinga
Axsome Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 14, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics to Report First Quarter 2023 Financial Results on May 8
April 13, 2023
Axsome to host conference call and webcast on Monday, May 8, 2023, at 8:00 a.m. Eastern Time
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
These Up-and-Coming Stocks Are Screaming Buys Right Now
April 13, 2023
Both companies could deliver revenue and share price growth over the long term.
Via
The Motley Fool
Can Axsome Hold Out Till Depression Drug Becomes a Blockbuster?
April 12, 2023
Has the company bitten off more than it can chew in R&D, or will its depression drug launch it into the stratosphere?
Via
The Motley Fool
A New Nasdaq Bull Market Is Nearly Here: 3 Stocks to Buy Sooner Rather Than Later
April 08, 2023
These stocks share one big thing in common -- huge growth prospects.
Via
The Motley Fool
Has Axsome Therapeutics Become a No-Brainer Buy?
April 05, 2023
The stock has been red-hot over the past year, and analysts remain bullish on it.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.